Last reviewed · How we verify
Placebo vaginal lubricant
A placebo vaginal lubricant provides no active pharmacological effect and serves as a control comparator in clinical trials.
A placebo vaginal lubricant provides no active pharmacological effect and serves as a control comparator in clinical trials. Used for Control arm in clinical trials for vaginal dryness or related conditions.
At a glance
| Generic name | Placebo vaginal lubricant |
|---|---|
| Also known as | placebo, Replens |
| Sponsor | Seoul National University Hospital |
| Modality | Small molecule |
| Therapeutic area | Gynecology |
| Phase | Phase 3 |
Mechanism of action
Placebo vaginal lubricants are inert formulations used in phase 3 trials to establish efficacy of active vaginal lubricant candidates through comparison against a non-therapeutic control. They mimic the physical properties and administration route of active treatments but contain no bioactive ingredients, allowing researchers to isolate the true therapeutic benefit of investigational agents.
Approved indications
- Control arm in clinical trials for vaginal dryness or related conditions
Common side effects
Key clinical trials
- Treatment of Vulvo-vaginal Atrophy (VVA) Using Vaginal Dilator in Addition to Usual Treatment (NA)
- Lidocaine for Pessary Check Pain Reduction (PHASE3)
- The Effectiveness of Transvaginal Radiofrequency in Women With Stress Urinary Incontinence (NA)
- Safety and Efficacy of Vaginal Microbiota Transplant (VMT) in Women With Bacterial Vaginosis (BV) (PHASE1)
- Self-Administered Lidocaine Gel for Pain Management With IUD Insertion (PHASE3)
- Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity (PHASE3)
- Functionality of Male Condoms With a Silicone Elastomer Vaginal RIng (PHASE1)
- Impact of Lactate-Containing Vaginal Lubricant on Sexual Dysfunction in Young Breast Cancer Survivors (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo vaginal lubricant CI brief — competitive landscape report
- Placebo vaginal lubricant updates RSS · CI watch RSS
- Seoul National University Hospital portfolio CI